The Office of the Surgeon General in the United States has released its second annual Skin Cancer Prevention Progress Report, which includes evidence-based strategies and a map of the status of US laws in relation to sunbeds.
Recent research has identified notable biomarkers in cancer stem-like cells (CSCs) that can be used as novel targets for diagnosis and treatment of tumor resistance in melanoma patients.
Recent articles identify lack of US consumer knowledge about the safety and efficacy of sunscreens as well as risk-busting information that can be provided by clinicians.
Future sun protection messages should include a focus on the importance of staying in the shade or indoors during periods of high UV radiation to increase awareness of the efficacy of these methods of avoiding skin cancer, according to authors of an Australian adolescent study.
The epidemiologic and clinical differences for in situ and invasive melanomas support further examination into the variations in etiologic pathways, according to authors of this study.
This article reviews the recent data on checkpoint inhibition in melanoma along with a brief review of other immunotherapeutic approaches, including the encouraging and expanding role of radiation therapy in integrated immunotherapy.
Skin-protection interventions that lessen the aura of invincibility around adolescent females’ understanding of their risk for developing skin cancers are vital to reducing the incidence of malignant melanoma, according to study authors.
Conducted by Honorary Associate Professor Amanda Oakley, this one-day course in Christchurch on 9 July will address clinical and dermatoscopic diagnosis of common benign and malignant skin lesions, particularly pigmented lesions.
Conducted by Honorary Associate Professor Amanda Oakley, this one-day course in Christchurch on 9 July will address clinical and dermatoscopic diagnosis of common benign and malignant skin lesions, particularly pigmented lesions.
Conducted by Honorary Associate Professor Amanda Oakley, this one-day course in Christchurch on 9 July will address clinical and dermatoscopic diagnosis of common benign and malignant skin lesions, particularly pigmented lesions.